From Seattle Life Sciences 2029 Photo Gallery:

hakala2029

hakala2029—

Doug Hakala posing a provocative question to the audience about competition with China and India.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

From Our Editors · Podcast
Xcelerating Life Sciences San Francisco: The Highlights Podcast
The AI, Big Data, and R&D Boom

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Xconomy on Demand

We offer a number of ways to subscribe for free!